Document is current

Article History

Received: 4 August 2025

Accepted: 17 August 2025

First Online: 4 September 2025

Declarations

:

: Alejandro Pérez Fidalgo reports Advisory Board, Speaker, Grant-Non-financial Support from Astrazeneca, GSK; Advisory Board, Speaker, Grant from Pharmamar; Advisory Board, Speaker from PharmaAnd, Deciphera and MSD; Advisory Board from Regeneron, Daichii Sankyo and Karyopharm. Adela Cañete reports grants from Norgine and Astra Zeneca; advisory board member for Norgine Spain and Recordati. José Gómez Codina reports Advisory Board from Ferrer, Roche, Astra Zeneca, Pfizer, MSD, Bristol-MS, Takeda, Accord, Casen-Recordati, Kite-Gilead, Ferrer; participation in medical meetings organised by Ferrer, Roche, Astra Zeneca, Pfizer, MSD, Bristol-MS, Takeda, Accord, Casen-Recordati, Bayer, Janssen, Kite-Gilead. Alberto Moreno Vega reports speaker invited from Novartis. Teresa López-Fernandez Speaker fees and advisory honoraria from Philips, Myocardial solutions, Janssen-Cilag, Astra Zeneca, Accord, Pfizer, Lilly not related with this work. Pilar Alonso, Maitane Andión, Erica Collado, Xavier Díaz Carrasco, Ramón García Sanz, Carmen Garrido Colino, Sergio Hernández Expósito, Gabriela Medin, Antonio Molinés, Iñigo San Miguel, Joaquín Sánchez García and Fátima Santolaya declare that they have no conflict of interest in relation to this article.

: The manuscript does not contain clinical studies or patient data.